Sensus Healthcare (NASDAQ:SRTS) Releases Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Sensus Healthcare (NASDAQ:SRTS) issued its quarterly earnings results on Wednesday. The company reported $0.09 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.10 by ($0.01), Zacks reports. Sensus Healthcare had a net margin of 22.54% and a return on equity of 17.99%.

Sensus Healthcare Stock Down 32.4 %

Shares of NASDAQ SRTS opened at $6.08 on Friday. Sensus Healthcare has a 12-month low of $2.91 and a 12-month high of $9.33. The firm’s 50-day simple moving average is $7.49 and its 200 day simple moving average is $6.89. The company has a market cap of $99.65 million, a price-to-earnings ratio of 10.67 and a beta of 1.24.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Lake Street Capital initiated coverage on Sensus Healthcare in a report on Friday, January 31st. They set a “buy” rating and a $18.00 price objective on the stock. Maxim Group boosted their price target on Sensus Healthcare from $12.00 to $14.00 and gave the company a “buy” rating in a research note on Friday, November 15th. Finally, HC Wainwright increased their price objective on Sensus Healthcare from $10.00 to $11.00 and gave the stock a “buy” rating in a research note on Monday, November 18th.

About Sensus Healthcare

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.